Jim Gilligan, PhD, MBIS

home / authors / jim-gilligan-phd-mbis

Dr Gilligan is the chief science officer and interim CEO of Tryp Therapeutics.

Articles

The Gut-Brain Connection: An Upcoming Study on Psilocybin-Assisted Psychotherapy and Irritable Bowel Syndrome

August 14th 2023

A phase 2A trial recently received confirmation to proceed in investigating psilocybin-assisted psychotherapy in the treatment of adult patients with IBS.

Psychedelics for the Treatment of Binge Eating Disorder in Males

Leah Kuntz;Jim Gilligan, PhD, MBIS

August 29th 2022

This new study is evaluating how effective psychedelics can be in the treatment of binge eating disorder.

Latest Updated Articles

Published: May 20th 2025 | Updated: May 22nd 2025

Nassir Ghaemi, MD, MPH, Explores SRIs at APA Annual Meeting

Published: March 19th 2021 | Updated: May 22nd 2025

Mini Quiz: Treatment for Pedophilia?

Published: April 5th 2017 | Updated: May 22nd 2025

Mini Quiz: Integrative Child Psychiatry

Published: May 19th 2025 | Updated: May 22nd 2025

Teaching Resilience at the 2025 APA Annual Meeting

Published: May 18th 2025 | Updated: May 22nd 2025

Serious Mental Illness, Substance Use Disorders, and Long-Acting Injectables in the Emergency Setting

Published: August 3rd 2015 | Updated: May 22nd 2025

Mini Quiz: DSM-5 Basics

Do Not Sell My Personal Information

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777